search
Back to results

Implementation of a Structured Post-pulmonary Embolism Follow-up Model

Primary Purpose

Pulmonary Embolism

Status
Recruiting
Phase
Not Applicable
Locations
Denmark
Study Type
Interventional
Intervention
Attend-PE model
Sponsored by
Aalborg University Hospital
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional health services research trial for Pulmonary Embolism focused on measuring Implementation, Health related quality of life, Intervention, Pulmonary embolism, Health care model

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria: CT-verified diagnosis of PE Expected survival at least 12 months at the time of PE Exclusion Criteria:

Sites / Locations

  • Aalborg University HospitalRecruiting

Arms of the Study

Arm 1

Arm Type

Experimental

Arm Label

Attend-PE

Arm Description

Outcomes

Primary Outcome Measures

Change in The Pulmonary Embolism Quality of Life (PEmb-QoL) questionnaire
42 item covering health-related quality of life after pulmonary embolism. Transformed scale show score from 0-100, where 0 is the worst outcome and 100 is the best outcome.

Secondary Outcome Measures

Change in EuroQol 5 Dimensions (EQ-5D)
Covering general Health in five dimension. The scores fall on a scale of -0.757 (worst health state) to 1.0 (best health state).
Change in Post-VTE Functional Status Scale (PFVS)
Covering functional status in 5 categories of functional limitations. In total 5 grades of functional limitations, where 1 is the worst grade and 5 is the best grade.
Change in Anti-Clot Treatment Scale (ACTS)
Covering satisfaction with anticoagulant treatment (12-item ACTS Burdens scale and 3-item ACTS Benefits scale). 5-point to 7-point scales, where higher scores indicate higher satisfaction with treatment.
Change in General Anxiety Disorder-7 (GAD7)
Covering anxiety. Score from 0-3 and total score range from 0 to 21, where 21 is the worst outcome and 0 is the best outcome.
Change in Patient Health Questionnaire (PHQ-9)
Covering depression. Score from 0-3 and total score range from 0 to 27, where 27 is the worst outcome and 0 is the best outcome.
Change in Patient Activation Measure (PAM)
Covering individual's knowledge, skills and confidence integral to managing one's own health and healthcare on a 4-point likert scale. Transformed scale show score from 0-100, where 0 is the worst outcome and 100 is the best outcome.
Change in Work Productivity and Activity Impairment questionnaire (WPAI:GH, v2.0.)
Covering work productivity and activity impairment (6 questions). WPAI outcomes are expressed as impairment percentages, with higher numbers indicating greater impairment and less productivity.

Full Information

First Posted
June 20, 2023
Last Updated
September 7, 2023
Sponsor
Aalborg University Hospital
Collaborators
Aarhus University Hospital
search

1. Study Identification

Unique Protocol Identification Number
NCT06037096
Brief Title
Implementation of a Structured Post-pulmonary Embolism Follow-up Model
Official Title
Implementation of a Structured Post-pulmonary Embolism Follow-up Model in a Danish Hospital Setting
Study Type
Interventional

2. Study Status

Record Verification Date
September 2023
Overall Recruitment Status
Recruiting
Study Start Date
March 15, 2022 (Actual)
Primary Completion Date
October 2025 (Anticipated)
Study Completion Date
October 2025 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Aalborg University Hospital
Collaborators
Aarhus University Hospital

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
Venous thromboembolism (VTE), clinically presenting as deep vein thrombosis or pulmonary embolism (PE) is the third most common cardiovascular disease and is associated with substantial short- and long-term morbidity and mortality and high costs of care. In addition negative physical and mental complications following VTE are common. However in terms of PE, there are no structured follow-up programs in Denmark and there is considerable variation in practice patterns of post-PE management both within and between countries. The Attend-PE project aims to develop, test and implement a structured follow-up model in a hospital setting for patients with pulmonary embolism. The Attend-PE is a pre-post intervention study and will estimate the effectiveness of implementing the structured care model on a national level.
Detailed Description
The pre-post intervention study aims to measure potential change in self-reported and clinical outcomes before and after the developed Attend-PE follow-up model has been implemented. For the pre-intervention period, patient-reported questionnaires and registry data will be collected on all persons having received a CT-verified diagnosis of PE in the period March 2022 - March 2023. At 6 and 12 months following the PE event, the patients will receive an online letter with an invitation to complete an online questionnaire. The questionnaire includes validated patient-reported outcome measures and questions about sociodemographic factors. Furthermore, for all patients who have been invited to participate, register data will be retrieved on use of health care services, sick leave, prescription medication, as well as information on hospital of admission. Thus, the last PROM and register data for the 12-month follow-up will be retrieved in March 2024. From April 2023 - September 2023 implementation of the Attend-PE model takes place on a national level, with a project team managing training of personnel and supporting the re-organization of care at the participating hospitals. 18 Danish hospitals have agreed to participate. Following the implementation of the Attend-PE model, the post-intervention period is initiated. From September 2023 - September 2024 a data collection period similar to the pre-intervention period will take place, with patient-reported questionnaires forwarded to patients following a diagnosis of PE at 6 and 12 months, and data from registries being collected in the same time period. Thus, the last 12-month follow-up is expected to be completed in September 2025. Detailed description of Attend-PE model: During hospitalization patients are given standardized patient information. This includes a written leaflet, oral information and links for online information (e.g., videos). An assessment of need for cancer screening is made, and in case of symptomatic DVT compressions stockings are provided. Before discharge patients are referred to a VTE clinic. Following discharge, patients and their relatives are invited to participate in a 2-hour group-based patient education session, ideally taking place within the first 2 weeks after discharge. This is managed by a nurse, physician and/or allied health professional and includes education about the condition, treatment, symptom management, physical and mental health, importance of physical activity and social support, and an overview of the care pathway. Time is given for questions and discussion with peers. Following the patient education, an individual follow-up consultation is offered, depending on an assessment of the individual patient's needs. This allows for a recapitulation of the previous information given, and specific questions or worries related to the individual patients' situation. At three months' post-discharge, patients are invited for a consultation with a physician at the VTE clinic. Prior to the consultation, the patient completes an online questionnaire in the waiting room, including validated questionnaires about treatment satisfaction (Anti-Clot Treatment Scale) and physical and mental wellbeing (Pulmonary Embolism Quality of Life with cascading questions about dyspnea (MRC), anxiety (GAD-7) and depression (PHQ-9). The physician uses the patient's responses actively during the consultation for discussion of continued treatment and assessment of whether further referral is required, i.e. to physiotherapist for assessment of physical function and rehabilitation needs, or to the GP for assessment of anxiety or depression and potential treatment hereof. If CTEPH is suspected, referral for VQ scan and/or echochardiography is made. Finally, referral for genetic testing may be considered if thrombophilia is suspected. For patients with provoked PE where medical treatment is completed at 3 months, and where none of the above referrals are required, patients are referred to their GP with standardized a discharge summary for the GP, and information material for the patient. For patients continuing medical treatment, a new consultation with a nurse is planned at 6 months, depending on the patients' needs. Core elements are adjustment of medication and assessment of physical and psychosocial well-being. For patients with individual needs due to complex health conditions, frailty, few psychosocial resources or similar, extra consultations may be provided during follow-up.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Pulmonary Embolism
Keywords
Implementation, Health related quality of life, Intervention, Pulmonary embolism, Health care model

7. Study Design

Primary Purpose
Health Services Research
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Model Description
Pre-post intervention study
Masking
None (Open Label)
Allocation
N/A
Enrollment
2000 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Attend-PE
Arm Type
Experimental
Intervention Type
Other
Intervention Name(s)
Attend-PE model
Other Intervention Name(s)
A structured post-pulmonary embolism follow-up model
Intervention Description
A pulmonary embolism follow-up care model consisting of structured elements for follow-up after discharge from hospital.
Primary Outcome Measure Information:
Title
Change in The Pulmonary Embolism Quality of Life (PEmb-QoL) questionnaire
Description
42 item covering health-related quality of life after pulmonary embolism. Transformed scale show score from 0-100, where 0 is the worst outcome and 100 is the best outcome.
Time Frame
Change from baseline to 6 month follow-up
Secondary Outcome Measure Information:
Title
Change in EuroQol 5 Dimensions (EQ-5D)
Description
Covering general Health in five dimension. The scores fall on a scale of -0.757 (worst health state) to 1.0 (best health state).
Time Frame
Change from baseline to 6 month follow-up
Title
Change in Post-VTE Functional Status Scale (PFVS)
Description
Covering functional status in 5 categories of functional limitations. In total 5 grades of functional limitations, where 1 is the worst grade and 5 is the best grade.
Time Frame
Change from baseline to 6 month follow-up
Title
Change in Anti-Clot Treatment Scale (ACTS)
Description
Covering satisfaction with anticoagulant treatment (12-item ACTS Burdens scale and 3-item ACTS Benefits scale). 5-point to 7-point scales, where higher scores indicate higher satisfaction with treatment.
Time Frame
Change from baseline to 6 month follow-up
Title
Change in General Anxiety Disorder-7 (GAD7)
Description
Covering anxiety. Score from 0-3 and total score range from 0 to 21, where 21 is the worst outcome and 0 is the best outcome.
Time Frame
Change from baseline to 6 month follow-up
Title
Change in Patient Health Questionnaire (PHQ-9)
Description
Covering depression. Score from 0-3 and total score range from 0 to 27, where 27 is the worst outcome and 0 is the best outcome.
Time Frame
Change from baseline to 6 month follow-up
Title
Change in Patient Activation Measure (PAM)
Description
Covering individual's knowledge, skills and confidence integral to managing one's own health and healthcare on a 4-point likert scale. Transformed scale show score from 0-100, where 0 is the worst outcome and 100 is the best outcome.
Time Frame
Change from baseline to 6 month follow-up
Title
Change in Work Productivity and Activity Impairment questionnaire (WPAI:GH, v2.0.)
Description
Covering work productivity and activity impairment (6 questions). WPAI outcomes are expressed as impairment percentages, with higher numbers indicating greater impairment and less productivity.
Time Frame
Change from baseline to 6 month follow-up

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: CT-verified diagnosis of PE Expected survival at least 12 months at the time of PE Exclusion Criteria:
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Anette A. Højen
Phone
+4529299114
Email
a.wind@rn.dk
First Name & Middle Initial & Last Name or Official Title & Degree
Stine F. Lindegaard
Phone
+4525545415
Email
s.lindegaard@rn.dk
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Anette A. Højen
Organizational Affiliation
Aalborg University Hospital
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
Nanna Rolving
Organizational Affiliation
Aarhus University Hospital
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
Søren P. Johnsen
Organizational Affiliation
Aalborg University
Official's Role
Principal Investigator
Facility Information:
Facility Name
Aalborg University Hospital
City
Aalborg
ZIP/Postal Code
9000
Country
Denmark
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Anette A. Højen
Phone
+4529299114
Email
a.wind@rn.dk
First Name & Middle Initial & Last Name & Degree
Stine F. Lindegaard
Phone
+4525545415
Email
s.lindegaard@rn.dk

12. IPD Sharing Statement

Learn more about this trial

Implementation of a Structured Post-pulmonary Embolism Follow-up Model

We'll reach out to this number within 24 hrs